Comment Below
minute read
ADVERTISEMENT
On Thursday, Elon Musk's artificial intelligence-driven brain implant company Neuralink received approval from the United States Food and Drug Administration to begin first-in-human clinical trials of its devices.
The move has been a long time coming, with Musk first suggesting that Neuralink would commence testing on humans in 2019.
"We are excited to share that we have received the FDA's approval to launch our first-in-human clinical study!" Neuralink tweeted.
"This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people."
The company noted that "recruitment is not yet open for our clinical trial," adding that it would "announce more information on this soon!"
As Reuters reports, Musk first sought permission from the FDA in early 2022, however their request was denied, with sources telling the outlet that the government agency had cited safety issues.
There has been much speculation regarding the potential uses of Neuralink. While some have compared it to a sci-fi-esque mind controlling device or dystopian internet to brain pipeline, in reality the technology will likely be utilized to aid those with neuralogical conditions.
"For the next few years, Neuralink is really just focused on restoring movement to people that have a broken neck or spine, and restoring vision," Musk explained in December. "So it's restoring movement and vision. It's not, you know, uploading memories, or controlling thoughts or anything like that. It's pretty basic stuff. It's like the early days of computers."
Similar techology was recently used to help a paralyzed Dutch man walk again. Gert-Jan Oskam, who hadn't taken a step in over a decade, was able to move around via two devices implanted in his brain and lower back that used AI to send signals to one another mimicking those generated by a functioning nervous system.
The move has been a long time coming, with Musk first suggesting that Neuralink would commence testing on humans in 2019.
"We are excited to share that we have received the FDA's approval to launch our first-in-human clinical study!" Neuralink tweeted.
"This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people."
The company noted that "recruitment is not yet open for our clinical trial," adding that it would "announce more information on this soon!"
As Reuters reports, Musk first sought permission from the FDA in early 2022, however their request was denied, with sources telling the outlet that the government agency had cited safety issues.
There has been much speculation regarding the potential uses of Neuralink. While some have compared it to a sci-fi-esque mind controlling device or dystopian internet to brain pipeline, in reality the technology will likely be utilized to aid those with neuralogical conditions.
"For the next few years, Neuralink is really just focused on restoring movement to people that have a broken neck or spine, and restoring vision," Musk explained in December. "So it's restoring movement and vision. It's not, you know, uploading memories, or controlling thoughts or anything like that. It's pretty basic stuff. It's like the early days of computers."
Similar techology was recently used to help a paralyzed Dutch man walk again. Gert-Jan Oskam, who hadn't taken a step in over a decade, was able to move around via two devices implanted in his brain and lower back that used AI to send signals to one another mimicking those generated by a functioning nervous system.
ADVERTISEMENT
ADVERTISEMENT
Join and support independent free thinkers!
We’re independent and can’t be cancelled. The establishment media is increasingly dedicated to divisive cancel culture, corporate wokeism, and political correctness, all while covering up corruption from the corridors of power. The need for fact-based journalism and thoughtful analysis has never been greater. When you support The Post Millennial, you support freedom of the press at a time when it's under direct attack. Join the ranks of independent, free thinkers by supporting us today for as little as $1.
Remind me next month
To find out what personal data we collect and how we use it, please visit our Privacy Policy
